ADAR1 Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

ADAR1 Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,923	Closed	-$1.07M	–	297
2026 Q1	$1.07M	Buy	+49,923	New	+$703K	0.06%	152
2025 Q4	–	Sell	-28,023	Closed	-$198K	–	275
2025 Q3	$198K	Hold	28,023	–	–	0.02%	181
2025 Q2	$182K	Hold	28,023	–	–	0.03%	157
2025 Q1	$222K	Sell	28,023 -25,000	-47%	-$269K	0.04%	140
2024 Q4	$672K	Sell	53,023 -88	-0.2%	-$1.22K	0.13%	100
2024 Q3	$740K	Buy	53,111 +18,011	+51%	+$257K	0.12%	94
2024 Q2	$484K	Buy	+35,100	New	+$514K	0.09%	101

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's DAWN Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 49,923 shares — an estimated $1.07M sold.

ADAR1 Capital Management first reported a position in DAWN in Q2 2024 and held it in 7 quarters. The position peaked at $1.07M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

ADAR1 Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
ADAR1 Capital Management sold 49,923 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.07M.
ADAR1 Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 7 quarters.
ADAR1 Capital Management's Day One Biopharmaceuticals position peaked at $1.07M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.